1.
Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in Resurface 1. J of Skin. 2020;4(5):s40. doi:10.25251/skin.4.supp.40